Prostate cancer from the horizon of the patient

Acta Oncologica

Volumn 50, Issue SUPPL. 1, 2011, Pages 148-154

  Denis, Louis J ^a   Roobol, Monique ^b   Dourcy Belle Rose, Brigitte ^a  

^a Oncology Centre of Antwerp   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AWARENESS; CLINICAL PROTOCOL; DOCTOR PATIENT RELATION; EUROPE; HEALTH CARE QUALITY; HUMAN; INFORMATION DISSEMINATION; MEDICAL CARE; MEDICAL ETHICS; MEDICAL RESEARCH; MEDICAL SOCIETY; PATIENT ADVOCACY; PATIENT CARE; PATIENT EDUCATION; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROSTATE CANCER; QUALITY OF LIFE; SUPPORT GROUP; TREATMENT PLANNING;

HUMANS; MALE; PATIENT ADVOCACY; PATIENT PARTICIPATION; PATIENT RIGHTS; PATIENT-CENTERED CARE; PROSTATIC NEOPLASMS;

EID: 79957469556     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.528446     Document Type: Article

References (14)

1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-81.
2. One step closer to patients' rights. HSCNEWS International 2009;49.
3. Denis L. Europa Uomo. BJU Int 2007;99:1329-34.
4. Van Daele H. Prostaatkanker, 2009. Wat zijn de feiten? PROSTAATinfo, 2009;8:4-5.
5. Denis L. Cancer Prostatique localis é d é butant: Surveillance active ou traitement imm é diat? Andrologic 2009;5:123-6.
6. Dourcy-Belle-Rose B. Prostaatproblemen. Gids voor mannen en vrouwen. 4th ed. OCA; Antwerp. 2010.
7. van Muilekom HAM, Spil JA. Handboek Prostaatcarcinoom. Elsevier Gezondheidszorg; Amsterdam. 2006.
8. Bangma CH. Het prostaat pensioen plan. Elsevier Gezondheidszorg; Rotterdam. 2008.
9. Kirkali Z. There has to be a way. Eur Urol 2007;52:1558-9. (Pubitemid 350052403)
10. Tannock IF, Osoba D, Stockler MR, et al. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points. J Clin Oncol 1996;14:1756-64. (Pubitemid 26185452)
11. Bangma CH, van den Bergh RCN, Denis L, Roobol MJ. Understanding active surveillance. A new treatment option for PSA positive low risk prostate cancer. Central Eur J Urol 2009;62:70-3.
12. Valdagni R, Scardino PT, Denis L, Kattan MW. Predictive modeling in prostate cancer: A conference summary. Eur Urol 2009;55:300-2.
13. European Association of Urology. Pocket guidelines. 2010 edition. EAU 2010. Available from: https://www.uroweb.org/ publications/eau-guidelines/
14. Roobol MJ, Kerkhof M, Schroder FH, et al. Prostate cancer mortality reduction by prostate-specifi c antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2009;56:584-91.